TECHNICAL SEMINAR - BRUKER DALTONIK  

Overcoming the Challenges of Intact Biotherapeutics Characterization with Ultra-High Resolution Mass Spectrometers and the Latest in Automated Biopharmaceutical Software Package – Biopharma Compass 2.0

 

WHEN? From 12.35 to 14.10 on Day 1 (31st October

 

WHO CAN ATTEND? Any participant registered for the World Biosimilar Congress

 

PRESENTED BY:

Catherine Evans, Bruker Catherine Evans

Business Development Manager Europe (Pharma/Biopharma)

Bruker

Attendees of this technology seminar will hear about the latest advancements in ultrahigh-resolution time-of-flight hardware and their application to the analytical challenges facing innovators and biosimilars characterization labs.  

Innovations in hardware, software and application-specific workflows will be highlighted.  In particular, the use of MALDI- and LC-TOF hardware in combination, all acquired and visualized with a single, ease-to-use, 21CFR Part 11 compliant software package; Biopharma Compass 2.0.

Several case studies involving monoclonal antibodies characterization will be presented to highlight: How high-confidence (high resolution) intact/subunit workflows improves labs productivity and; how automation of routine data processing tasks improves the system utilization time.

 

**IMPORTANT** To take part in the seminar, you must have registered to attend the World Biosimilar Congress 2017 or its colocated events, the European Antibody Congress and the World Immunotherapy Congress.

 

 

world biosimilar congress panel discussion

 

 

REGISTER NOW TO THE SEMINAR

 

Get involved

To sponsor or exhibit the World Biosimilar Congress, contact Derek Cavanagh
on +44 (0) 207 0921 297 or email  derek.cavanagh@terrapinn.com